申请人:Glaxo Inc.
公开号:US05187305A1
公开(公告)日:1993-02-16
The present invention relates to the compounds of formula (I), ##STR1## wherein R.sup.1 is C.sub.1-8 alkyl; C.sub.5-8 cycloalkyl;--(CH.sub.2).sub.n --Si(CH.sub.3).sub.3, wherein n is 1 to 5; C.sub.2-5 alkylenyl; arylmethylene; aryl; heteroaryl; or wherein such aryl or heteoaryl bears 1 to 3 substituents independently selected from halogen, amino, C.sub.1-8 alkyl mono- or disubstituted amino, C.sub.1-8 alkyl and C.sub.1-8 alkoxy and R.sup.2 is C.sub.1-8 alkoxy, pharmaceutical formulations containing these compounds and their use as vasodilators and in the treatment of cardiovascular disorders.
本发明涉及式(I)的化合物,其中R1是C1-8烷基;C5-8环烷基;--(CH2)n--Si(CH3)3,其中n为1至5;C2-5烷基亚基;芳基甲亚基;芳基;杂芳基;或其中所述的芳基或杂芳基独立地带有1至3个取代基,所述取代基选自卤素,氨基,C1-8烷基单取代或双取代氨基,C1-8烷基和C1-8烷氧基,R2是C1-8烷氧基,以及包含这些化合物的制药配方和它们作为血管扩张剂和治疗心血管疾病的用途。